Nomura Asset Management Co. Ltd. purchased a new stake in shares of Amrize Ltd (NYSE:AMRZ – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 155,360 shares of the company’s stock, valued at approximately $8,402,000.
Other hedge funds also recently bought and sold shares of the company. Basepoint Wealth LLC purchased a new stake in Amrize during the fourth quarter valued at $33,000. Laurel Wealth Advisors LLC purchased a new stake in Amrize during the fourth quarter valued at $34,000. State of Wyoming purchased a new stake in Amrize during the third quarter valued at $32,000. US Bancorp DE purchased a new stake in Amrize during the third quarter valued at $38,000. Finally, Costello Asset Management INC purchased a new stake in Amrize during the third quarter valued at $44,000.
Amrize Stock Performance
Shares of AMRZ opened at $53.86 on Thursday. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38. The business has a 50-day simple moving average of $54.44 and a two-hundred day simple moving average of $55.28. The stock has a market cap of $29.79 billion and a price-to-earnings ratio of 25.77. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $65.94.
Amrize Cuts Dividend
The business also recently declared a dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a $0.11 dividend. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio is presently 21.05%.
Analysts Set New Price Targets
AMRZ has been the topic of several recent research reports. Truist Financial lowered their price objective on shares of Amrize from $75.00 to $65.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Berenberg Bank set a $70.00 target price on shares of Amrize in a research report on Thursday, February 19th. Royal Bank Of Canada decreased their price target on shares of Amrize from $61.00 to $60.00 and set a “sector perform” rating on the stock in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Amrize in a research note on Monday, February 23rd. Finally, Wells Fargo & Company cut their price objective on shares of Amrize from $66.00 to $65.00 and set an “overweight” rating for the company in a research report on Wednesday, April 15th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $64.86.
Read Our Latest Research Report on Amrize
Insider Buying and Selling
In related news, CTO Roald Brouwer purchased 1,500 shares of Amrize stock in a transaction on Thursday, May 21st. The stock was acquired at an average price of $49.84 per share, for a total transaction of $74,760.00. Following the completion of the transaction, the chief technology officer directly owned 19,757 shares in the company, valued at $984,688.88. This represents a 8.22% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Mario Gross purchased 1,200 shares of Amrize stock in a transaction on Wednesday, May 20th. The stock was bought at an average price of $48.63 per share, with a total value of $58,356.00. Following the transaction, the insider owned 34,747 shares of the company’s stock, valued at approximately $1,689,746.61. This represents a 3.58% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have acquired 131,554 shares of company stock worth $7,152,069. Corporate insiders own 0.54% of the company’s stock.
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Articles
- Five stocks we like better than Amrize
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
